title: Regulation of Adaptive Immunity in Health and Disease by Cholesterol Metabolism.
abstract: Four decades ago, it was observed that stimulation of T cells induces rapid changes in cellular cholesterol that are required before proliferation can commence. Investigators returning to this phenomenon have finally revealed its molecular underpinnings. Cholesterol trafficking and its dysregulation are now also recognized to strongly influence dendritic cell function, T cell polarization, and antibody responses. In this review, the state of the literature is reviewed on how cholesterol and its trafficking regulate the cells of the adaptive immune response and in vivo disease phenotypes of dysregulated adaptive immunity, including allergy, asthma, and autoimmune disease. Emerging evidence supporting a potential role for statins and other lipid-targeted therapies in the treatment of these diseases is presented. Just as vascular biologists have embraced immunity in the pathogenesis and treatment of atherosclerosis, so should basic and clinical immunologists in allergy, pulmonology, and other disciplines seek to encompass a basic understanding of lipid science.
authors.affiliation: Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, 111 T.W. Alexander Drive, Maildrop D2-01, P.O. Box 12233, Research Triangle Park, NC, 27709, USA, fesslerm@niehs.nih.gov.
authors.forename: Michael B
authors.initials: MB
authors.lastname: Fessler
mesh_terms: D056704:Adaptive Immunity; D001402:B-Lymphocytes / Q000276:immunology; D001692:Biological Transport; D002784:Cholesterol / Q000378:metabolism*; D006801:Humans; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000276:immunology
chemical_list: D002784:Cholesterol